Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 235

    1.

    Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

    Dullaart RP, Perton F, Kappelle PJ, de Vries R, Sluiter WJ, van Tol A.

    Biochim Biophys Acta. 2009 Oct 1. [Epub ahead of print]PMID: 19800416 [PubMed - as supplied by publisher]Related articles

    2.

    Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.

    van Haperen R, Samyn H, van Gent T, Zonneveld AJ, Moerland M, Grosveld F, Jansen H, Dallinga-Thie GM, van Tol A, de Crom R.

    Biochim Biophys Acta. 2009 Oct;1791(10):1031-6. Epub 2009 Jun 11.PMID: 19524061 [PubMed - in process]Related articles

    3.

    Reduction of HDL levels lowers plasma PLTP and affects its distribution among lipoproteins in mice.

    Samyn H, Moerland M, van Gent T, van Haperen R, van Tol A, de Crom R.

    Biochim Biophys Acta. 2009 Aug;1791(8):790-6. Epub 2009 May 5.PMID: 19422933 [PubMed - indexed for MEDLINE]Related articles

    4.

    Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.

    Dallinga-Thie GM, van Tol A, Dullaart RP; Diabetes Atorvastatin lipid intervention (DALI) study group.

    Biochim Biophys Acta. 2009 Aug;1791(8):714-8. Epub 2009 Mar 19.PMID: 19303940 [PubMed - indexed for MEDLINE]Related articles

    5.

    Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Voorbij HA, Sluiter WJ, van Tol A.

    Eur J Clin Invest. 2009 Mar;39(3):200-3.PMID: 19260949 [PubMed - indexed for MEDLINE]Related articles

    6.

    Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.

    van Hoek M, van Tol A, van Vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM.

    Curr Med Res Opin. 2009 Jan;25(1):93-101.PMID: 19210142 [PubMed - indexed for MEDLINE]Related articles

    7.

    Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.

    Samyn H, Moerland M, van Gent T, van Haperen R, Grosveld F, van Tol A, de Crom R.

    Atherosclerosis. 2009 Jun;204(2):429-34. Epub 2008 Oct 30.PMID: 19100548 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.

    van Tol A, van Rijswijk J.

    Eur Arch Otorhinolaryngol. 2009 Oct;266(10):1655-7. Epub 2008 Dec 4.PMID: 19052763 [PubMed - in process]Related articlesFree article

    9.

    Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness.

    Dullaart RP, Perton F, Sluiter WJ, de Vries R, van Tol A.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4860-6. Epub 2008 Sep 9.PMID: 18782872 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.

    Samyn H, Moerland M, van Gent T, van Haperen R, Metso J, Grosveld F, Jauhiainen M, van Tol A, de Crom R.

    J Lipid Res. 2008 Dec;49(12):2504-12. Epub 2008 Aug 18.PMID: 18711210 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.

    van Haperen R, Samyn H, Moerland M, van Gent T, Peeters M, Grosveld F, van Tol A, de Crom R.

    PLoS One. 2008 May 28;3(5):e2255.PMID: 18509527 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Torcetrapib and coronary events.

    Dullaart RP, Kobold AC, van Tol A.

    N Engl J Med. 2008 Apr 24;358(17):1863; author reply 1863-4. No abstract available. PMID: 18437725 [PubMed - indexed for MEDLINE]Related articles

    13.

    Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.

    Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R.

    Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1277-82. Epub 2008 Apr 17.PMID: 18421000 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.

    Dallinga-Thie GM, Dullaart RP, van Tol A.

    Curr Diab Rep. 2008 Feb;8(1):65-70. Review.PMID: 18367001 [PubMed - indexed for MEDLINE]Related articles

    15.

    The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity.

    Borggreve SE, de Vries R, Dallinga-Thie GM, Wolffenbuttel BH, Groen AK, van Tol A, Dullaart RP.

    Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):10-5. Epub 2007 Dec 15.PMID: 18178167 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.

    Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A.

    Eur J Endocrinol. 2008 Jan;158(1):53-60.PMID: 18166817 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis.

    Levels JH, Pajkrt D, Schultz M, Hoek FJ, van Tol A, Meijers JC, van Deventer SJ.

    Biochim Biophys Acta. 2007 Dec;1771(12):1429-38. Epub 2007 Oct 12.PMID: 17980169 [PubMed - indexed for MEDLINE]Related articles

    18.

    Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.

    Dullaart RP, de Vries R, Dallinga-Thie GM, Sluiter WJ, van Tol A.

    Clin Endocrinol (Oxf). 2008 Mar;68(3):375-81. Epub 2007 Sep 18.PMID: 17877759 [PubMed - indexed for MEDLINE]Related articles

    19.

    Appraisal of hepatic lipase and lipoprotein lipase activities in mice.

    Dallinga-Thie GM, Zonneveld-de Boer AJ, van Vark-van der Zee LC, van Haperen R, van Gent T, Jansen H, De Crom R, van Tol A.

    J Lipid Res. 2007 Dec;48(12):2788-91. Epub 2007 Sep 13.PMID: 17872590 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.

    Moerland M, Samyn H, van Gent T, Jauhiainen M, Metso J, van Haperen R, Grosveld F, van Tol A, de Crom R.

    J Lipid Res. 2007 Dec;48(12):2622-31. Epub 2007 Aug 29.PMID: 17761633 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.

    Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW.

    Curr Med Res Opin. 2007 Sep;23(9):2235-40.PMID: 17692153 [PubMed - indexed for MEDLINE]Related articles

    22.

    Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.

    Dullaart RP, Dallinga-Thie GM, van Tol A.

    Clin Endocrinol (Oxf). 2007 Aug;67(2):316-7; author reply 317. Epub 2007 May 24. No abstract available. PMID: 17524037 [PubMed - indexed for MEDLINE]Related articles

    23.

    Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.

    Dallinga-Thie GM, Dullaart RP, van Tol A.

    Curr Opin Lipidol. 2007 Jun;18(3):251-7. Review.PMID: 17495597 [PubMed - indexed for MEDLINE]Related articles

    24.

    Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.

    Moerland M, Anghelescu N, Samyn H, van Haperen R, van Gent T, Strouboulis J, van Tol A, Grosveld F, de Crom R.

    Transgenic Res. 2007 Aug;16(4):503-13. Epub 2007 Apr 17.PMID: 17437182 [PubMed - indexed for MEDLINE]Related articles

    25.

    High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.

    Borggreve SE, Hillege HL, Dallinga-Thie GM, de Jong PE, Wolffenbuttel BH, Grobbee DE, van Tol A, Dullaart RP; PREVEND Study Group.

    Eur Heart J. 2007 Apr;28(8):1012-8. Epub 2007 Apr 4.PMID: 17409111 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee.

    Brouwer GM, van Tol AW, Bergink AP, Belo JN, Bernsen RM, Reijman M, Pols HA, Bierma-Zeinstra SM.

    Arthritis Rheum. 2007 Apr;56(4):1204-11.PMID: 17393449 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender.

    Dullaart RP, de Vries R, van Tol A, Sluiter WJ.

    Eur J Endocrinol. 2007 Mar;156(3):387-94.PMID: 17322499 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.

    de Vries R, Groen AK, Perton FG, Dallinga-Thie GM, van Wijland MJ, Dikkeschei LD, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Atherosclerosis. 2008 Feb;196(2):733-41. Epub 2007 Feb 1.PMID: 17275009 [PubMed - indexed for MEDLINE]Related articles

    29.

    CETP inhibition in cardiovascular risk management: a critical appraisal.

    Dullaart RP, Dallinga-Thie GM, Wolffenbuttel BH, van Tol A.

    Eur J Clin Invest. 2007 Feb;37(2):90-8. Review. Erratum in: Eur J Clin Invest. 2007 May;37(5):434. PMID: 17217373 [PubMed - indexed for MEDLINE]Related articles

    30.

    Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.

    van der Steeg WA, Hovingh GK, Klerkx AH, Hutten BA, Nootenboom IC, Levels JH, van Tol A, Dallinga-Thie GM, Zwinderman AH, Kastelein JJ, Kuivenhoven JA.

    J Lipid Res. 2007 Mar;48(3):674-82. Epub 2006 Dec 27.PMID: 17192423 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Dallinga-Thie GM, van Tol A, Sluiter WJ.

    Biochim Biophys Acta. 2007 Jan;1771(1):113-8. Epub 2006 Nov 15. Erratum in: Biochim Biophys Acta. 2007 Apr;1771(4):564. PMID: 17185032 [PubMed - indexed for MEDLINE]Related articles

    32.

    Large variations in absolute wall shear stress levels within one species and between species.

    Cheng C, Helderman F, Tempel D, Segers D, Hierck B, Poelmann R, van Tol A, Duncker DJ, Robbers-Visser D, Ursem NT, van Haperen R, Wentzel JJ, Gijsen F, van der Steen AF, de Crom R, Krams R.

    Atherosclerosis. 2007 Dec;195(2):225-35. Epub 2006 Dec 12. Review.PMID: 17169362 [PubMed - indexed for MEDLINE]Related articles

    33.

    Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.

    Lie J, Moerland M, van Gent T, van Haperen R, Scheek L, Sadeghi-Niaraki F, de Crom R, van Tol A.

    Biochim Biophys Acta. 2006 Sep;1761(9):1070-7. Epub 2006 Jul 20.PMID: 16935026 [PubMed - indexed for MEDLINE]Related articles

    34.

    Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.

    Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW.

    Atherosclerosis. 2007 Jul;193(1):129-34. Epub 2006 Jun 13.PMID: 16777114 [PubMed - indexed for MEDLINE]Related articles

    35.

    Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

    Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ; DALI study group.

    Diabetologia. 2006 Jul;49(7):1505-11. Epub 2006 Apr 28.PMID: 16752169 [PubMed - indexed for MEDLINE]Related articles

    36.

    An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group.

    J Clin Endocrinol Metab. 2006 Sep;91(9):3382-8. Epub 2006 May 9.PMID: 16684835 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?

    Dallinga-Thie GM, van Tol A, Hattori H, Rensen PC, Sijbrands EJ.

    Diabetes. 2006 May;55(5):1491-6.PMID: 16644710 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Alcohol.

    Hendriks HF, van Tol A.

    Handb Exp Pharmacol. 2005;(170):339-61. Review.PMID: 16596806 [PubMed - indexed for MEDLINE]Related articles

    39.

    Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.

    de Vries R, Dallinga-Thie GM, Smit AJ, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Diabetologia. 2006 Feb;49(2):398-404. Epub 2005 Dec 23.PMID: 16374627 [PubMed - indexed for MEDLINE]Related articles

    40.

    A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.

    De Vries R, Beusekamp BJ, Kerstens MN, Groen AK, Van Tol A, Dullaart RP.

    Scand J Clin Lab Invest. 2005;65(8):729-37.PMID: 16319046 [PubMed - indexed for MEDLINE]Related articles

    41.

    Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.

    de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Diabetes. 2005 Dec;54(12):3554-9.PMID: 16306375 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein.

    Lie J, Lankhuizen IM, Gross B, van Gent T, van Haperen R, Scheek L, Staels B, de Crom R, van Tol A.

    Biochim Biophys Acta. 2005 Dec 30;1738(1-3):48-53. Epub 2005 Nov 2.PMID: 16298159 [PubMed - indexed for MEDLINE]Related articles

    43.

    Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.

    Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP.

    Nephrol Dial Transplant. 2006 Jan;21(1):101-6. Epub 2005 Sep 2.PMID: 16141462 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.

    De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP.

    Clin Lab. 2005;51(7-8):403-9.PMID: 16122151 [PubMed - indexed for MEDLINE]Related articles

    45.

    Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.

    Oomen PH, van Tol A, Hattori H, Smit AJ, Scheek LM, Dullaart RP.

    Diabet Med. 2005 Jun;22(6):768-74.PMID: 15910630 [PubMed - indexed for MEDLINE]Related articles

    46.

    Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytes.

    Van den Top AM, Van Tol A, Jansen H, Geelen MJ, Beynen AC.

    J Dairy Res. 2005 May;72(2):129-37.PMID: 15909677 [PubMed - indexed for MEDLINE]Related articles

    47.

    Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.

    de Vries R, Kerstens MN, Sluiter WJ, Groen AK, van Tol A, Dullaart RP.

    Diabetologia. 2005 Jun;48(6):1105-13. Epub 2005 May 5.PMID: 15875154 [PubMed - indexed for MEDLINE]Related articles

    48.

    The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group.

    J Clin Endocrinol Metab. 2005 Jul;90(7):4198-204. Epub 2005 Apr 19.PMID: 15840744 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    A novel common variant -181 G insertion in the promoter of the gene for phospholipid transfer protein.

    Palmen J, Colhoun HM, Van Tol A, Hattori H, Humphries SE.

    Atherosclerosis. 2005 May;180(1):211-3. No abstract available. PMID: 15823296 [PubMed - indexed for MEDLINE]Related articles

    50.

    Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.

    van Wijk JP, Buirma R, van Tol A, Halkes CJ, De Jaegere PP, Plokker HW, van der Helm YJ, Castro Cabezas M.

    Atherosclerosis. 2005 Jan;178(1):147-55.PMID: 15585212 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...